Aerosolized Aldesleukin in Treating Patients With Lung Metastases

Summary

This phase I/II trial studies the side effects and best dose of aerosolized aldesleukin and to see how well it works in treating patients with cancer that has spread from the original tumor to the lungs. Biological therapies, such as aerosolized aldesleukin, may stimulate or suppress the immune system in different ways and stop tumor cells from growing.

Timeline

Start

2012-06-28

Primary completion

2029-04-30

Completion

2029-04-30

Drugs

Indications